Dalhousie University
🇨🇦Canada
BioVaxys and Sona Nanotech Partner to Develop Novel Cancer Immunotherapy Combining DPX Platform with Gold Nanorod Technology
BioVaxys Technology and Sona Nanotech have formed a research collaboration to develop innovative cancer therapeutics by combining BioVaxys' DPX immune educating platform with Sona's targeted hyperthermia therapy using gold nanorods.
Ablation Shows Superior Outcomes as First-Line Treatment for Ventricular Tachycardia Post-Heart Attack
A new study suggests ablation should be considered as a first-line treatment for ventricular tachycardia (VT) in heart attack survivors, rather than a secondary option after medication failure.